ICD-10-PCS Codes Deleted in

64 codes were deleted from the 2023 ICD-10-PCS code set, effective October 1, 2022.

Displaying codes 1-64 of 64:

  • 5A0512C Extracorporeal Supersaturated Oxygenation, Intermittent
  • 5A0522C Extracorporeal Supersaturated Oxygenation, Continuous
  • D0Y0KZZ Laser Interstitial Thermal Therapy of Brain
  • D0Y1KZZ Laser Interstitial Thermal Therapy of Brain Stem
  • D0Y6KZZ Laser Interstitial Thermal Therapy of Spinal Cord
  • D0Y7KZZ Laser Interstitial Thermal Therapy of Peripheral Nerve
  • DBY0KZZ Laser Interstitial Thermal Therapy of Trachea
  • DBY1KZZ Laser Interstitial Thermal Therapy of Bronchus
  • DBY2KZZ Laser Interstitial Thermal Therapy of Lung
  • DBY5KZZ Laser Interstitial Thermal Therapy of Pleura
  • DBY6KZZ Laser Interstitial Thermal Therapy of Mediastinum
  • DBY7KZZ Laser Interstitial Thermal Therapy of Chest Wall
  • DBY8KZZ Laser Interstitial Thermal Therapy of Diaphragm
  • DDY0KZZ Laser Interstitial Thermal Therapy of Esophagus
  • DDY1KZZ Laser Interstitial Thermal Therapy of Stomach
  • DDY2KZZ Laser Interstitial Thermal Therapy of Duodenum
  • DDY3KZZ Laser Interstitial Thermal Therapy of Jejunum
  • DDY4KZZ Laser Interstitial Thermal Therapy of Ileum
  • DDY5KZZ Laser Interstitial Thermal Therapy of Colon
  • DDY7KZZ Laser Interstitial Thermal Therapy of Rectum
  • DDY8KZZ Laser Interstitial Thermal Therapy of Anus
  • DFY0KZZ Laser Interstitial Thermal Therapy of Liver
  • DFY1KZZ Laser Interstitial Thermal Therapy of Gallbladder
  • DFY2KZZ Laser Interstitial Thermal Therapy of Bile Ducts
  • DFY3KZZ Laser Interstitial Thermal Therapy of Pancreas
  • DGY0KZZ Laser Interstitial Thermal Therapy of Pituitary Gland
  • DGY1KZZ Laser Interstitial Thermal Therapy of Pineal Body
  • DGY2KZZ Laser Interstitial Thermal Therapy of Adrenal Glands
  • DGY4KZZ Laser Interstitial Thermal Therapy of Parathyroid Glands
  • DGY5KZZ Laser Interstitial Thermal Therapy of Thyroid
  • DMY0KZZ Laser Interstitial Thermal Therapy of Left Breast
  • DMY1KZZ Laser Interstitial Thermal Therapy of Right Breast
  • DVY0KZZ Laser Interstitial Thermal Therapy of Prostate
  • X2RF032 Replacement of Aortic Valve using Zooplastic Tissue, Rapid Deployment Technique, Open Approach, New Technology Group 2
  • X2RF332 Replacement of Aortic Valve using Zooplastic Tissue, Rapid Deployment Technique, Percutaneous Approach, New Technology Group 2
  • X2RF432 Replacement of Aortic Valve using Zooplastic Tissue, Rapid Deployment Technique, Percutaneous Endoscopic Approach, New Technology Group 2
  • XHRPXL2 Replacement of Skin using Porcine Liver Derived Skin Substitute, External Approach, New Technology Group 2
  • XK02303 Introduction of Concentrated Bone Marrow Aspirate into Muscle, Percutaneous Approach, New Technology Group 3
  • XRG0092 Fusion of Occipital-cervical Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2
  • XRG00F3 Fusion of Occipital-cervical Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3
  • XRG1092 Fusion of Cervical Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2
  • XRG10F3 Fusion of Cervical Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3
  • XRG2092 Fusion of 2 or more Cervical Vertebral Joints using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2
  • XRG20F3 Fusion of 2 or more Cervical Vertebral Joints using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3
  • XRG4092 Fusion of Cervicothoracic Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2
  • XRG40F3 Fusion of Cervicothoracic Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3
  • XRG6092 Fusion of Thoracic Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2
  • XRG60F3 Fusion of Thoracic Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3
  • XRG7092 Fusion of 2 to 7 Thoracic Vertebral Joints using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2
  • XRG70F3 Fusion of 2 to 7 Thoracic Vertebral Joints using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3
  • XRG8092 Fusion of 8 or more Thoracic Vertebral Joints using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2
  • XRG80F3 Fusion of 8 or more Thoracic Vertebral Joints using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3
  • XRGA092 Fusion of Thoracolumbar Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2
  • XRGA0F3 Fusion of Thoracolumbar Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3
  • XRGB092 Fusion of Lumbar Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2
  • XRGB0F3 Fusion of Lumbar Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3
  • XRGC092 Fusion of 2 or more Lumbar Vertebral Joints using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2
  • XRGC0F3 Fusion of 2 or more Lumbar Vertebral Joints using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3
  • XRGD092 Fusion of Lumbosacral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2
  • XRGD0F3 Fusion of Lumbosacral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3
  • XW03392 Introduction of Defibrotide Sodium Anticoagulant into Peripheral Vein, Percutaneous Approach, New Technology Group 2
  • XW033A3 Introduction of Bezlotoxumab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 3
  • XW04392 Introduction of Defibrotide Sodium Anticoagulant into Central Vein, Percutaneous Approach, New Technology Group 2
  • XW043A3 Introduction of Bezlotoxumab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 3